$BEIGENE(06160)$ view order de

$BEIGENE(06160)$ view order details.@Trade Feed Decoder

06160

06-17 10:43

HKBEIGENE

Side	Price \| Filled	Realized P&L
Sell Close	156.40 200	-9.58% Closed

BEIGENE

Trade Feed: Who is your favorite trader?

Come to the Trade Feed Topic to find more trading opportunities! Also, please feel free to recommend and introduce fellow Tigers to the "hidden gem traders" that you've discovered!

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Trade Feed Decoder
06-17
Trade Feed Decoder
Analysis of BEIGENE (06160) trade: The 9.58% loss suggests a challenging entry or exit strategy, possibly influenced by recent volatility in biotech stocks. Selling at $156.4 reflects a risk-limiting decision, which could indicate disciplined adherence to pre-set stop-loss thresholds or reassessment of fundamental catalysts. Given the sector's sensitivity to clinical trial outcomes and regulatory news, the timing might align with evolving company-specific developments. While the loss highlights short-term misalignment with market sentiment, the proactive exit avoids prolonged exposure to uncertainty. Traders could interpret this as a case study in balancing conviction with adaptive risk management, emphasizing the importance of aligning position sizing with volatility expectations in speculative sectors like biotech.

Leave a comment

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":446903084056832,"tweetId":"446903084056832","gmtCreate":1750128514869,"gmtModify":1750129241880,"author":{"id":3583928578091433,"idStr":"3583928578091433","authorId":3583928578091433,"authorIdStr":"3583928578091433","name":"KyrieYang","avatar":"https://community-static.tradeup.com/news/c1cd774bbc2c6182472a3bdb9c2afed8","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":12,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":25,"starInvestorFlag":true,"fullDisclosureFlag":true,"starInvestorFollowerNum":25,"starInvestorOrderShareNum":169,"userFollowInvestorFlag":false,"orderNotificationFlag":false,"ror":10.02,"showRor":true,"investmentPhilosophy":"focus on high potential tech stocks","winRationPercentage":48.387097,"tradeVolumeEst":0},"themes":[{"themeId":"4e1ab37448a24dd39b7882426fc6fd27","categoryId":"ab3d937a5fd848c08008411a9be702b5","name":"Trade Feed: Who is your favorite trader?","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":4e1ab37448a24dd39b7882426fc6fd27}&rnconfig={\"headerBarHidden\": true}","description":"Come to the Trade Feed Topic to find more trading opportunities! Also, please feel free to recommend and introduce fellow Tigers to the \"hidden gem traders\" that you've discovered!","image":"https://community-static.tradeup.com/news/e496e574dd744490c7b4f7959f83f5a4"}],"images":[],"coverImages":[],"html":"<html><head></head><body><a href=\"https://ttm.financial/S/06160\">$BEIGENE(06160)$&nbsp;</a>view order details.<a href=\"https://ttm.financial/U/10000000000011061\">@Trade Feed Decoder</a></body></html>","htmlText":"<html><head></head><body><a href=\"https://ttm.financial/S/06160\">$BEIGENE(06160)$&nbsp;</a>view order details.<a href=\"https://ttm.financial/U/10000000000011061\">@Trade Feed Decoder</a></body></html>","text":"$BEIGENE(06160)$ view order details.@Trade Feed Decoder","highlighted":1,"essential":1,"paper":1,"likeSize":38,"commentSize":1,"repostSize":14,"favoriteSize":0,"link":"https://ttm.financial/post/446903084056832","repostId":0,"isVote":1,"tweetType":1,"viewCount":1588,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["06160"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":true,"orderData":{"uuid":"3583928578091433","orderId":"39482688770151424","kind":"TRADE","symbol":"06160","secType":"STK","symbolHtmlTag":"<a href=\"https://ttm.financial/S/06160\">$BEIGENE(06160)$&nbsp;</a>","symbolHtmlTagHref":"https://ttm.financial/S/06160","symbolName":"BEIGENE","market":"HK","action":"SELL","currency":"HKD","symbolLogo":"https://static.tigerbbs.com/fb1c31328866892c1bec13d76f5bb9d6","showFilledQuantity":true,"nameCN":"BEIGENE","orderType":"LMT","filledQuantityFinal":200,"avgFillPrice":156.4,"createTime":1750128210,"filledQuantity":"200","filledQuantityScale":"0","openFlag":false,"side":"DEBIT","contractMajorDescription":"BEIGENE","contractExtraDescription":"06160","legs":[],"completedFlag":true,"orderPnl":{"realizedPnlPercent":-0.0958,"realizedPnlByAveragePercent":-0.0321},"quickOrderFlag":false},"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":["订单分享帖","未分享订单分享帖"],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":34,"optionInvolvedFlag":false,"xxTargetLangEnum":"ORIG"},"commentList":[{"id":446983743406376,"commentId":"446983743406376","gmtCreate":1750133139142,"gmtModify":1750133365597,"authorId":10000000000011060,"author":{"id":10000000000011060,"idStr":"10000000000011061","authorId":10000000000011060,"name":"Trade Feed Decoder","avatar":"https://community-static.tradeup.com/news/4dc8fec78bad5acffbf563bdbc6bc8ed","vip":4,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":446903084056832,"objectIdStr":"446903084056832","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"Analysis of BEIGENE (06160) trade:  \nThe 9.58% loss suggests a challenging entry or exit strategy, possibly influenced by recent volatility in biotech stocks. Selling at $156.4 reflects a risk-limiting decision, which could indicate disciplined adherence to pre-set stop-loss thresholds or reassessment of fundamental catalysts. Given the sector's sensitivity to clinical trial outcomes and regulatory news, the timing might align with evolving company-specific developments. While the loss highlights short-term misalignment with market sentiment, the proactive exit avoids prolonged exposure to uncertainty. Traders could interpret this as a case study in balancing conviction with adaptive risk management, emphasizing the importance of aligning position sizing with volatility expectations in speculative sectors like biotech.","text":"Analysis of BEIGENE (06160) trade:  \nThe 9.58% loss suggests a challenging entry or exit strategy, possibly influenced by recent volatility in biotech stocks. Selling at $156.4 reflects a risk-limiting decision, which could indicate disciplined adherence to pre-set stop-loss thresholds or reassessment of fundamental catalysts. Given the sector's sensitivity to clinical trial outcomes and regulatory news, the timing might align with evolving company-specific developments. While the loss highlights short-term misalignment with market sentiment, the proactive exit avoids prolonged exposure to uncertainty. Traders could interpret this as a case study in balancing conviction with adaptive risk management, emphasizing the importance of aligning position sizing with volatility expectations in speculative sectors like biotech.","html":"Analysis of BEIGENE (06160) trade:  \nThe 9.58% loss suggests a challenging entry or exit strategy, possibly influenced by recent volatility in biotech stocks. Selling at $156.4 reflects a risk-limiting decision, which could indicate disciplined adherence to pre-set stop-loss thresholds or reassessment of fundamental catalysts. Given the sector's sensitivity to clinical trial outcomes and regulatory news, the timing might align with evolving company-specific developments. While the loss highlights short-term misalignment with market sentiment, the proactive exit avoids prolonged exposure to uncertainty. Traders could interpret this as a case study in balancing conviction with adaptive risk management, emphasizing the importance of aligning position sizing with volatility expectations in speculative sectors like biotech.","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"hot","coins":0,"score":0,"disclaimerFlag":true,"disclaimerType":1,"specialCommentTag":"AI_ANALYSE"}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/446903084056832"}